alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 1311.135 Requirements for creating a controlled substance prescription. ( a ) The electronic prescription application may allow the registrant or his agent to enter data for a controlled substance prescription, provided that only the registrant may sign the prescription in accordance with §§ 1311.120(b)(11) and 1311.140.
( b ) If a practitioner holds multiple DEA registrations, the practitioner or his agent must select the appropriate registration number for the prescription being issued in accordance with the requirements of § 1301.12 of this chapter.
( c ) If required by State law, a supervisor's name and DEA number may be listed on a prescription, provided the prescription clearly indicates who is the supervisor and who is the prescribing practitioner.
§ 1114.49 Electronic submission. ( a ) *Electronic format requirement.* Applicants submitting any documents to the Agency under this part must provide all required information to FDA using the Agency's electronic system, except as provided in paragraph (b) of this section. The application and all supporting information must be submitted in an electronic format that FDA can process, review, and archive.
( b ) *Waivers from electronic format requirement.* An applicant may submit a written request, that is legible and in English, to the Center for Tobacco Products asking that FDA waive the requirement for electronic format and content. Waivers will be granted if use of electronic means is not reasonable for the applicant. To request a waiver, applicants can send the written request to the address included on our website (*www.fda.gov/tobacco-products*). The request must include the following information: ( 1 ) The name and address of the applicant, a list of individuals authorized by the applicant to serve as the contact person and contact information. If the applicant has submitted a PMTA previously, the regulatory correspondence should also include any identifying information about the previous submission.
( 2 ) A statement that creation and/or submission of information in electronic format is not reasonable for the applicant, and an explanation of why creation and/or submission in electronic format is not reasonable. This statement must be signed by the applicant or by a representative who is authorized to make the declaration on behalf of the applicant.
( c ) *Paper submission.* An applicant who has obtained a waiver from filing electronically must send a written application through the Document Control Center to the address provided in the FDA documentation granting the waiver.
§ 700.4 Exceptions. Consistent with 2 CFR 200.102(b): ( a ) Exceptions on a case-by-case basis for individual non-Federal entities may be authorized by USAID's Assistant Administrator, Bureau for Management, or designee as delegated in Agency policy, except where otherwise required by law or where OMB or other approval is expressly required by this Part. No case-by-case exceptions may be granted to the provisions of Subpart F—Audit Requirements of this Part.
( b ) USAID's Assistant Administrator, Bureau for Management, or designee as delegated in Agency policy, is also authorized to approve exceptions, on a class or an individual case basis, to USAID program specific assistance regulations other than those which implement statutory and executive order requirements.
( c ) The Federal awarding agency may apply more restrictive requirements to a class of Federal awards or non-Federal entities when approved by OMB, required by Federal statutes or regulations except for the requirements in Subpart F—Audit Requirements of this part. A Federal awarding agency may apply less restrictive requirements when making awards at or below the simplified acquisition threshold, or when making fixed amount awards as defined in Subpart A—Acronyms and Definitions of 2 CFR part 200, except for those requirements imposed by statute or in Subpart F—Audit Requirements of this part.
# EUR-Lex - 31992D0140 - EN

Avis juridique important

*|*

# 31992D0140

**92/140/EEC: Commission Decision of 12 February 1992 approving the plan for the approval of establishments for the purposes of intra-Community trade in poultry and hatching eggs submitted by Ireland (Only the English text is authentic) **

*
Official Journal L 058 , 03/03/1992 P. 0028 - 0028 *

COMMISSION DECISION of 12 February 1992 approving the plan for the approval of establishments for the purposes of intra-Community trade in poultry and hatching eggs submitted by Ireland (Only the English text is authentic) (92/140/EEC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Directive 90/539/EEC of 15 October 1990 on animal health conditions governing intra-Community trade in, and imports from third countries of, poultry and hatching eggs (1), as last amended by Directive 91/496/EEC (2), and in particular Article 3 (2) thereof,

Whereas by letter dated 4 July 1991 Ireland transmitted a plan to the Commission;

Whereas the plan has been examined and found to meet the requirements of Directive 90/539/EEC, and in particular Annex II thereof;

Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,

HAS ADOPTED THIS DECISION:

Article 1

The plan submitted by Ireland for the approval of establishments for the purposes of intra-Community trade in poultry and hatching eggs is hereby approved.

Article 2

Ireland shall bring into force by 1 May 1992 the laws, regulations and administrative provisions for implementation of the plan referred to in Article 1.

Article 3

This Decision is addressed to Ireland. Done at Brussels, 12 February 1992. For the Commission

Ray MAC SHARRY

Member of the Commission

(1) OJ No L 303, 31. 10. 1990, p. 6. (2) OJ No L 268, 24. 9. 1991, p. 56.
§ 111.105 What must quality control personnel do? Quality control personnel must ensure that your manufacturing, packaging, labeling, and holding operations ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. To do so, quality control personnel must perform operations that include: ( a ) Approving or rejecting all processes, specifications, written procedures, controls, tests, and examinations, and deviations from or modifications to them, that may affect the identity, purity, strength, or composition of a dietary supplement;
( b ) Reviewing and approving the documentation setting forth the basis for qualification of any supplier;
( c ) Reviewing and approving the documentation setting forth the basis for why meeting in-process specifications, in combination with meeting component specifications, will help ensure that the identity, purity, strength, and composition of the dietary supplement are met;
( d ) Reviewing and approving the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification selected under § 111.75(c)(1) will ensure that the finished batch of the dietary supplement meets product specifications;
( e ) Reviewing and approving the basis and the documentation for why any product specification is exempted from the verification requirements in § 111.75(c)(1), and for why any component and in-process testing, examination, or monitoring, or other methods will ensure that such exempted product specification is met without verification through periodic testing of the finished batch;
( f ) Ensuring that required representative samples are collected;
( g ) Ensuring that required reserve samples are collected and held;
( h ) Determining whether all specifications established under § 111.70(a) are met; and
( i ) Performing other operations required under this subpart.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-07-00541-CV

Shalanda Augillard, Appellant

v.

Tiffany Madura and Richard Toro, Appellee

FROM THE DISTRICT COURT OF HAYS COUNTY, 274TH JUDICIAL DISTRICT

NO. 06-0762, HONORABLE WILLIAM HENRY, JUDGE PRESIDING

C O N C U R R I N G O P I N I O N

I concur in the judgment only. 

__________________________________________

Jan P. Patterson, Justice

Before Justices Patterson, Puryear and Henson

Filed: June 20, 2008
IV 

115TH CONGRESS 

2D SESSION H. RES. 1033 

Recognizing the importance of access to comprehensive, high-quality, lifeaffirming medical care for women of all ages. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 26, 2018 

Mr. BIGGS submitted the following resolution; which was referred to the 

Committee on Energy and Commerce 

RESOLUTION 

Recognizing the importance of access to comprehensive, highquality, life-affirming medical care for women of all ages. 

Whereas women of all ages should have access to comprehensive, convenient, compassionate, life-affirming, high-quality medical services; 

Whereas all women should feel empowered and equipped with 

the knowledge to listen to their body and advocate for 

their health; 

Whereas health care for women should emphasize the whole 

woman, including her physical, mental, and spiritual 

wellness; 

Whereas health care for women should also address the needs 

of men, families, and communities as they relate to women’s health care; 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HRES 1033 IH 

Whereas health care centers should include access to social 

services that empower women to care for their health; 

Whereas Pro Women’s Healthcare Centers is a consortium of 

centers that serves as an example of the high-quality, 

comprehensive, life-affirming care that women deserve; 

Whereas every Pro Women’s Healthcare Center-certified clinic has a licensed medical professional; 

Whereas every Pro Women’s Healthcare Center offers comprehensive health services, including well-woman exams, 

sexually transmitted disease testing and treatment, 

breast exams, pregnancy testing, prenatal and pregnancy 

care, miscarriage support, fertility awareness instruction, 

infertility consultation, and onsite or nearby, direct referrals for material, emotional, practical, and spiritual resources; and 

Whereas Pro Women’s Healthcare Centers has certified 

health care centers nationwide that meet its standards 

for high-quality, life-affirming care and continue to do so: 

Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) expresses its support for women nationwide 

3 to have access to comprehensive, convenient, com4 passionate, life-affirming, high-quality health care; 

5 and 

6 (2) recognizes the high standards established by 

7 Pro Women’s Healthcare Centers consortium as 

8 standards worth implementing nationwide. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS
# L_2023173EN.01003001.xml

| 6.7.2023 | EN | Official Journal of the European Union | L 173/30 |
| --- | --- | --- | --- |

6.7.2023

EN

Official Journal of the European Union

L 173/30

---

DECISION OF THE EEA JOINT COMMITTEE No 132/2020

of 25 September 2020

amending Annex IX (Financial services) to the EEA Agreement [2023/1391]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Delegated Regulation (EU) 2018/1108 of 7 May 2018 supplementing Directive (EU) 2015/849 of the European Parliament and of the Council with regulatory technical standards on the criteria for the appointment of central contact points for electronic money issuers and payment service providers and with rules on their functions (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Delegated Regulation (EU) 2018/1108 of 7 May 2018 supplementing Directive (EU) 2015/849 of the European Parliament and of the Council with regulatory technical standards on the criteria for the appointment of central contact points for electronic money issuers and payment service providers and with rules on their functions (1) is to be incorporated into the EEA Agreement.

| (2) | Annex IX to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex IX to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following point is inserted after point 23bb (Commission Delegated Regulation (EU) 2016/1675) of Annex IX to the EEA Agreement:

| ‘23bc. | 32018 R 1108: Commission Delegated Regulation (EU) 2018/1108 of 7 May 2018 supplementing Directive (EU) 2015/849 of the European Parliament and of the Council with regulatory technical standards on the criteria for the appointment of central contact points for electronic money issuers and payment service providers and with rules on their functions (OJ L 203, 10.8.2018, p. 2).’ |
| --- | --- |

‘23bc.

32018 R 1108: Commission Delegated Regulation (EU) 2018/1108 of 7 May 2018 supplementing Directive (EU) 2015/849 of the European Parliament and of the Council with regulatory technical standards on the criteria for the appointment of central contact points for electronic money issuers and payment service providers and with rules on their functions (OJ L 203, 10.8.2018, p. 2).’

Article 2

The text of Delegated Regulation (EU) 2018/1108 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 26 September 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made. (*1)

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 25 September 2020.

For the EEA Joint Committee

The President

Sabine MONAUNI

---

(1)  
  OJ L 203, 10.8.2018, p. 2.

1

(*1)  No constitutional requirements indicated.

*1

---
#### § 1250.27 Storage of perishables.

All perishable food or drink shall be kept at or below 50 °F, except when being prepared or kept hot for serving.
_____________ No. 96-1783ND

_____________ John B. Fredericks, Jr.; * Judy Fredericks, * * Appellants, * * v. * * United States Department of * Agriculture; agent Dan Glickman;* Farmers Home Administration; * Odell O. Ottmar, in his * capacity as employee of the * Appeal from the United States Farmers Home Administration; * District Court for the District Lorace Hakanson, in his * of North Dakota. capacity as employee of the * Farmers Home Administration; * [UNPUBLISHED] Robert Zimmerman, in his * capacity as employee of the * Farmers Home Administration; * David Hilleren, in his capacity * as employee of the Farmers Home * Administration; Frederick R. * Young, director national * appeals staff, Farmers Home * Administration, * *

Appellees. *

_____________ Submitted: October 3, 1996 Filed: October 9, 1996

_____________ Before FAGG, WOLLMAN, and MURPHY, Circuit Judges.

_____________
PER CURIAM.
JohnB. Fredericks, Jr. and Judy Fredericks appeal the distric t court's order denying their request for attorney 's fees and expenses. The par ties' briefs discuss the merits of the underlying litigation, and w e need not repeat what they have said

### -2-

to decide whether there was substantial justific ation for the Government's position. Having considered the record and the parties' briefs, w e conclude the Government's position was substantially justified within the meaning of the Equal Access to Justice Act, 28 U.S.C. § 2412(d). We thus affirm the district court. See8th Cir. R. 47B.
A true copy.

Attest:
CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
#### § 417.620 Do Federal agencies coordinate suspension and debarment actions?

Yes, when more than one Federal agency has an interest in a suspension or debarment, the agencies may consider designating one agency as the lead agency for making the decision. Agencies are encouraged to establish methods and procedures for coordinating their suspension and debarment actions.
227 So.2d 590

#### Reverend Manno M. SNYDER v. AUTOMOBILE OWNERS SAFETY INSURANCE COMPANY and Standard Life & Accident Insurance Company.

No. 50092.

Nov. 10, 1969.

In re: Automobile Owners Safety Insurance Company and Standard Life & Accident Insurance Company applying for certiorari or writ of review, to the Court of Appeal, Fourth Circuit, Parish of Orleans. 225 So.2d 275.

Writ refused. There is no error in the judgment complained of.
Editorial Note on Part 106
Editorial Note: Nomenclature changes to part 106 appear at 81 FR 49895, July 29, 2016.

§ 106.92 Audits of quality control procedures. ( a ) A manufacturer of an infant formula, or an agent of such a manufacturer, shall conduct regularly scheduled audits to determine whether the manufacturer has complied with the requirements for quality control procedures that are necessary to ensure that an infant formula provides nutrients in accordance with section 412(b) and (i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(b) and (i)) and is manufactured in a manner designed to prevent adulteration of the infant formula under section 412(a)(1) and (a)(3) of the Federal Food, Drug, and Cosmetic Act. Such audits shall be conducted at a frequency that is required to ensure compliance with the requirements for quality control procedures.
( b ) The audits required by paragraph (a) of this section shall be performed by an individual or a team of individuals who, as a result of education, training, or experience, is knowledgeable in all aspects of infant formula production and of the regulations concerning quality control procedures that such individual or team is responsible for auditing. This individual or team of individuals shall have no direct responsibility for the matters that such individual or team is auditing and shall have no direct interest in the outcome of the audit.
#### § 781.3 [Reserved]
**Exhibit No. 32.1**

 

 

**CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**CERTIFICATIONS UNDER RULE 13a-14(b) OF THE EXCHANGE ACT**

 

 

Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, each of the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of BNCCORP, Inc. and Subsidiaries.

 

                
| Date: March 27, 2006 |   | BNCCORP, Inc.                                 |
|----------------------|--------|-----------------------------------------------|
|                 |   |                                          |
|                 | By     | /s/ Gregory K. Cleveland                      |
|                      |   | Gregory K. Cleveland

Chief Executive Officer |
|                 |   |                                          |
|                 | By     | /s/ Neil M. Brozen                            |
|                      |   | Neil M. Brozen 

Chief Financial Officer      |
EXHIBIT 32.1
                                                                    ------------

                                  CERTIFICATION
                PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
         OF 2002 (SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF
                          TITLE 18, UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers of National Datacomputer, Inc., a Delaware corporation (the
"Company"), does hereby certify, to such officer's knowledge, that:

The Quarterly Report on Form 10-Q for the period ended March 31, 2008 (the "Form
10-Q") of the Company fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, and the information contained in
the Form 10-Q fairly presents, in all material respects, the financial condition
and results of operations of the Company.


Dated: May 14, 2008                    /s/  William Berens
                                       -----------------------------------------
                                       William B. Berens
                                       President and  Chief Executive
                                       Officer

Dated: May 14, 2008                    /s/ Bruna Bucacci
                                       -----------------------------------------
                                       Bruna Bucacci
                                       Chief Accounting Officer

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
Exhibit 32.1

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350


         In connection with the accompanying Quarterly Report on Form 10-QSB of
Velocity Asset Management Inc. for the three months ended June 30, 2007, I, John
C. Kleinert, Chief Executive Officer of Velocity Asset Management, Inc. hereby
certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

         (1)      such Quarterly Report on Form 10-QSB for the three months
                  ended June 30, 2007, fully complies with the requirements of
                  section 13(a) or 15(d) of the Securities Exchange Act of 1934;
                  and

         (2)      the information contained in such Quarterly Report on Form
                  10-QSB for the three months ended June 30, 2007, fairly
                  presents, in all material respects, the financial condition
                  and results of operations of Velocity Asset Management, Inc.


                                       /s/ JOHN C. KLEINERT
                                       ----------------------------------------
                                       John C. Kleinert
                                       Chief Executive Officer


August 9, 2007


                                      -28-